Indee Labs

Indee Labs is a healthcare company located in Berkeley, California, with a team of five employees. It operates within the drug discovery and delivery sub-industry and was part of the Y-Combinator batch W17. The company focuses on the development and manufacturing of engineered cell therapies, particularly through its patented technology, Hydropore™. This technology employs microfluidic vortex shedding (µVS) to facilitate the rapid delivery of small molecules, nucleic acids, proteins, and gene-editing complexes to immune cells. Hydropore™ is designed to preserve cell viability and function, making it a critical tool in accelerating the discovery, development, and manufacturing processes of cell therapies. Currently, Hydropore™ is available for Research Use Only (RUO) and is developed in a regulatory-ready manner, ensuring that all materials in the flow path are either medical-grade or USP Class VI implantable-grade. The system is also suitable for high-throughput pooled screening of small volumes, catering to the needs of the United States, America/Canada, and remote regions.